Skip to content
AwardedSpainGoods€208,287

Suministro de los principios activos denominados "Fruquintinib MG" Y "Fruquintinib 1 MG".

Published
Published 25 September 2025

Overview

EL objeto del contrato viene determitado por el Suministro de los principios activos denominados "Fruquintinib MG" Y "Fruquintinib1 MG".

Key details

Country
Spain
Status
Awarded
Category
Goods
Estimated value
€208,287
Procedure
Direct
Published
25 September 2025
Classification (CPV)
Various medicinal products

Award outcome

Awarded value
€40,841
Award date
13 August 2025
Winner
  • Takeda Farmacéutica España, S.A.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    25 September 2025

Contracting authority

  • Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín

    Procuring entity

    Las Palmas de Gran Canaria, Spain

    ID_PLATAFORMA: 21050930148853

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Suministro de los principios activos denominados "Fruquintinib MG" Y "Fruquintinib 1 MG". — won by Takeda Farmacéutica España, S.A. — Skim